Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies
This study is currently recruiting participants.
Verified April 2013 by Onyx Pharmaceuticals
Onyx Therapeutics, Inc.
Information provided by (Responsible Party):
Onyx Pharmaceuticals ( Onyx Therapeutics, Inc. )
First received: August 11, 2011
Last updated: April 11, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2014|
|Estimated Primary Completion Date:||May 2014 (Final data collection date for primary outcome measure)|